Company Filing History:
3 out of 43 
3 out of 12 Years Active: 2013-2017
Title: The Innovative Journey of David Sabatino
Introduction: David Sabatino is a notable inventor based in Montreal, Canada, recognized for his contributions to the field of biotechnology. With a total of three patents to his name, Sabatino's work focuses on novel compounds that hold significant potential in medical applications.
Latest Patents: Among his latest innovations are two patents related to azapeptides as CD36 binding compounds. These compounds, described by the formula I: A-(Xaa)-N(R)—N(R)—C(O)-(Xaa')-B, are designed to interact with CD36, a receptor implicated in various biological functions and diseases. This cutting-edge research positions Sabatino at the forefront of therapeutic development.
Career Highlights: Throughout his career, David Sabatino has demonstrated an unwavering commitment to research and innovation. His experience includes valuable tenures at Valorisation-Recherche Limited Partnership and Valorisation Hsj Limited Partnership, where he honed his expertise in biotechnology and pharmaceuticals.
Collaborations: Collaboration has been key to Sabatino's success. He has worked alongside talented individuals such as Huy Ong and Sylvain Chemtob, whose insights have enhanced his research endeavors. These partnerships underscore the importance of teamwork in advancing scientific knowledge and innovation.
Conclusion: David Sabatino's journey as an inventor is marked by significant achievements in the field of biotechnology. His innovative patents reflect his dedication to creating impactful solutions in medicine. As he continues to explore new frontiers in research, Sabatino's work serves as an inspiration to fellow inventors and innovators in the industry.